grant
Influence of the Menopausal Transition and Lifetime Ovarian Exposure on Neural Metabolism, Connectivity and Pathology
Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 15 Mar 2024Deadline 28 Feb 2029
NIHUS FederalResearch GrantFY2025AD dementiaAD pathologyAPOEAbscissionAccelerationAccountingAffectAgeAllelesAllelomorphsAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer risk factorAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimer's biomarkerAlzheimer's disease biological markerAlzheimer's disease pathologyAlzheimer's disease riskAlzheimer's pathologyAlzheimers DementiaAlzheimer’s biological markerAlzheimer’s disease biomarkerAmyloidAmyloid SubstanceAmyloid depositionApo-EApoE proteinApolipoprotein EAquadiolBiological MarkersBrainBrain Nervous SystemBrain regionCellular ExpansionCellular GrowthCerebrumCharacteristicsCognitionCognitiveDevelopmentDifferences between sexesDiffers between sexesDimenformonDiogynDiogynetsEncephalonEstraceEstradiolEstradiol-17 betaEstradiol-17betaEstraldineEstrogensExcisionExposure toExtirpationFoundationsFunctional MRIFunctional Magnetic Resonance ImagingGenesGenetic PredispositionGenetic Predisposition to DiseaseGenetic RiskGenetic SusceptibilityGenetic propensityGenotypeImpairmentIndividualInherited PredispositionInherited SusceptibilityIntermediary MetabolismInvestigatorsLaboratoriesLeadLightMeasuresMediatingMemoryMenarcheMenopausal StatusMenopauseMetabolicMetabolic ProcessesMetabolismMidlife womenModelingNerve DegenerationNeuron DegenerationNeuronal InjuryOvarianOvarian hormoneOvocyclinOvocylinPETPET ScanPET imagingPETSCANPETTParticipantPathologyPatternPb elementPerformancePerimenopausalPerimenopausePersonsPhotoradiationPlayPositron Emission Tomography Medical ImagingPositron Emission Tomography ScanPositron-Emission TomographyPost-MenopausePost-menopausal PeriodPostmenopausal PeriodPostmenopausePre-MenopausePre-menopausal PeriodPremature MenopausePremenopausalPremenopausal PeriodPremenopausePrimary Senile Degenerative DementiaProcessProgynonPubertyPublic HealthRad.-PETRemovalResearchResearch PersonnelResearchersRestRiskRisk ReductionRoleSample SizeSamplingSex DifferencesSexual differencesSurgical RemovalSymptomsSynaptic plasticityTestingTherapeutic EstradiolTherapeutic EstrogenWomanafter menopauseagesalzheimer riskamyloid pathologybio-markersbiologic markerbiomarkerbrain metabolismcell growthcerebralcognitive functiondevelop therapydevelopmentalearly menopauseexperiencefMRIfemale at midlifefollowing menopausegenetic etiologygenetic mechanism of diseasegenetic vulnerabilitygenetically predisposedglucose metabolismheavy metal Pbheavy metal leadintervention developmentlater in lifelater lifelife spanlifespanmenmenopause transitionmid lifemid-lifemid-life femalemiddle agemiddle agedmiddle-aged femalemiddle-aged womenmidlifeneuralneural degenerationneural imagingneural modelneuro-imagingneurodegenerationneurodegenerativeneuroimagingneurological degenerationneurological imagingneuron developmentneuron injuryneuronal degenerationneuronal developmentpast menopauseperi-menopausalperi-menopausepositron emission tomographic (PET) imagingpositron emission tomographic imagingpositron emitting tomographypost-menopausalpostmenopausalpostmenopausal statuspre-menopausalpremature age of menopausepremenopausal statusprimary degenerative dementiaprotective effectreduce riskreduce risksreduce that riskreduce the riskreduce these risksreduces riskreduces the riskreducing riskreducing the riskresectionresilienceresilientrisk-reducingsenile dementia of the Alzheimer typesex based differencessex-dependent differencessex-related differencessex-specific differencessocial rolesynapse functionsynaptic functiontherapy developmenttransition to menopausetransitional menopausetreatment developmentwomen at midlifewomen in midlife
Description preview
Women are significantly more likely to develop Alzheimer’s disease than men, making up 2/3 of all AD cases.
Growing evidence suggests that this difference is related to the decline in ovarian hormone levels experienced
by women at midlife through menopause. Women who experience menopause later in life, and thus have a
longer lifespan exposure to…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click